Scientific Advisors Archives - NFCR

Scott Lippman, M.D.
Director, Moores Cancer Center, UC San Diego Health Scott M. Lippman, MD, is director of Moores Cancer Center at UC San Diego Health, professor of Medicine at UC San Diego School of Medicine, senior associate dean and associate vice chancellor for Cancer Research and Care and holds the Chugai Pharmaceutical…...
Thea Tlsty, Ph.D.
Professor of Pathology & Director of the Center for Translational Research in the Molecular Genetics of Cancer, University of California San Francisco Director for the Program in Cell Cycling and Signaling, UCSF Helen Diller Family Comprehensive Cancer Center Dr. Thea Tlsty is Professor of Pathology at the University of California,…...
Susan Band Horwitz, Ph.D.
Distinguished Professor Emerita, Department of Molecular Pharmacology & Rose C. Falkenstein Chair in Cancer Research, Albert Einstein College of Medicine Dr. Horwitz is an American biochemist and distinguished professor emerita at the Albert Einstein College of Medicine. Dr. Horwitz grew up in Boston, went to Bryn Mawr College and received…...
Frederick W. Alt, Ph.D.
Charles A. Janeway Professor of Pediatrics & Professor of Genetics, Harvard Medical School Investigator, Howard Hughes Medical Institute, Boston Children’s Hospital Dr. Frederick Alt received his Ph.D. in Biology from Stanford University in 1977 where he worked with Robert Schimke. He moved to MIT for postdoctoral work with David Baltimore,…...
Peter K. Vogt, Ph.D.
Professor of Molecular Medicine, Scripps Research Institute Dr. Peter Vogt is a molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes. Dr. Vogt received his undergraduate education in biology at the University of Würzburg and in 1959 was awarded his Ph.D. at the University…...
Kanaga Sabapathy, Ph.D.
Head, Division of Cellular and Molecular Research, National Cancer Center Singapore Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995. After a post-doctoral stint at the Institute of Molecular Pathology in Vienna, Austria, he moved to…...
Brian Leyland-Jones, MBBS, Ph.D.
Chief Medical Officer
Brian Leyland-Jones BSc (1st Class Hons), MB BS, LRCP, MRCS, ECFMG, PhD, FACP, FRCPC Dr. Leyland-Jones is a past Chief of Developmental Therapeutics at the National Cancer Institute (NCI) and has served as principal, co-principal, and co-investigator on more than 100 clinical studies. While at the NCI. he coordinated the…...
Ruggero De Maria, M.D.
President, Alliance Against Cancer; Director, Institute of Pathology, Catholic University, Rome, Italy Professor Ruggero De Maria obtained his M.D. at the University of Catania (1989) and completed his residence training in endocrinology at the University of Palermo (1994). During his postdoc at the Department of Experimental Medicine, University of Rome,…...
Webster Cavenee, Ph.D.
Director of Strategic Alliances, Ludwig Institute for Cancer Research Distinguished Professor of Medicine, University of California San Diego Dr. Cavenee did his graduate and postdoctoral training in cell biology, biochemistry and human genetics. He received his Ph.D. with honors in 1977 from the University of Kansas Medical School and then…...